About
About The Event
Agenda
Get Involved
Programs
In-Person Breakouts
Short Courses
Plenary Sessions
Speaker Biographies
Training Seminar
Attendees
Search the Agenda
Networking
Archives
Sponsor/Exhibitor
Attendee Demographics + Event Features
Sponsorship Opportunities
Current Sponsors
Current Exhibitors
Exhibit Services Schedule
Exhibitor Prospectus
Lead Generation Opportunities
FAQs
Sponsor & Exhibitor Portal
Best of Show Awards
Media
Media Partners
Downloads
Media Gallery
Travel
Posters
Poster Information
Poster Titles
Register
Individual Pricing
Group Pricing
On Demand Pricing
Archives
Discovery on Target - September 30-October 3, 2024
Discovery on Target - September 25-28, 2023
Discovery on Target - October 17-20, 2022
Discovery on Target - September 27-30, 2021
Discovery on Target - September 15-18, 2020
Discovery on Target - September 16-19, 2019
Discovery on Target - September 25-28, 2018
Discovery on Target - September 25-29, 2017
Discovery on Target - September 19-22, 2016
Discovery on Target - September 21-24, 2015
Discovery on Target - October 8-10, 2014
Discovery on Target - September 24-26, 2013
Discovery on Target - October 1-3, 2012
Discovery on Target - November 2-4, 2011
Discovery on Target - November 2-4, 2010
Discovery on Target - November 2-4, 2009
#BostonDOT
Conference Programs
September 22
Covalent Chemistries & Induced Proximity
Strategies for Targeting Kinases
Emerging Immune Modulation Strategies
3D Models & NAMs in Drug Development
Synthetic Biology for Drug Discovery & Development
September 23-24
Degraders & Molecular Glues – Part 1
Emerging Drug Targets: Identification & Validation
Small Molecules for Cancer Targets
Antibodies Against Membrane Protein Targets
RNA & DNA Targeting Small Molecule Drugs
AI/ML-Enabled Drug Discovery - Part 1
Targeting MASH & Obesity
NEW
September 24-25
Degraders & Molecular Glues – Part 2
Lead Generation Strategies
Emerging Cancer Targets for Multispecifics, ADCs, and Biologics
GPCR-Based Drug Discovery
Targeting Transcription Factors & Regulators
AI/ML-Enabled Drug Discovery - Part 2
TS: Drug Exposure at the Target: The Role of ADME and Pharmacokinetics